These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2088853)

  • 1. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
    Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
    Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
    Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
    Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
    Mehta JL; Nicolini FA; Lawson DL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
    Przyklenk K; Kloner RA
    Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between carnosine and captopril on free radical scavenging activity and angiotensin-converting enzyme activity in vitro.
    Nakagawa K; Ueno A; Nishikawa Y
    Yakugaku Zasshi; 2006 Jan; 126(1):37-42. PubMed ID: 16394648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.
    Suzuki S; Sato H; Shimada H; Takashima N; Arakawa M
    Pharmacology; 1993 Jul; 47(1):61-5. PubMed ID: 8393194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free radical scavenging properties of alacepril metabolites and lisinopril.
    Noda Y; Mori A; Packer L
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
    Mira ML; Silva MM; Queiroz MJ; Manso CF
    Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
    Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
    J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
    Mak IT; Freedman AM; Dickens BF; Weglicki WB
    Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
    Mira ML; Silva MM; Queirós MJ; Manso C
    Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?
    McMurray J; Chopra M
    Br J Clin Pharmacol; 1991 Apr; 31(4):373-9. PubMed ID: 2049244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
    Obata T; Yamanaka Y
    J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril inhibits the fluorescence development associated with glycation of proteins.
    Le Guen CA; Bain S; Barnett AH; Lunec J
    Agents Actions; 1992 Jul; 36(3-4):264-70. PubMed ID: 1529807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
    Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
    J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury.
    Przyklenk K; Kloner RA
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):167S-175S. PubMed ID: 2690907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
    Anning PB; Grocott-Mason RM; Lewis MJ
    Endothelium; 1997; 5(4):265-75. PubMed ID: 9588818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury: an overview.
    Zughaib ME; Sun JZ; Bolli R
    Basic Res Cardiol; 1993; 88 Suppl 1():155-67. PubMed ID: 8357331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.